Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response
- PMID: 22497512
- DOI: 10.1111/j.1399-3089.2012.00697.x
Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response
Abstract
Background: CD4(+) CD25(+) FoxP3(+) regulatory T (Treg) cells play an important role in regulating immune responses. A very small number of Treg cells are present in peripheral blood and lymphoid organs, but due to their ability to suppress the immune response, they have a high potential for immunotherapy in clinics. Successful ex-vivo expansion of naturally occurring CD4(+) CD25(+) T cells has been achieved after TCR stimulation in the presence of T cell growth factors. In this study, we evaluated the role of these Treg cells in suppressing proliferative response of baboon T and B cells to pig xenoantigens.
Methods: Naturally occurring baboon CD4(+) CD25(+) regulatory T cells (nTreg) were sorted from peripheral blood and expanded in the presence of either anti-CD3/CD28 beads or irradiated pig peripheral blood mononuclear cells with IL-2. Treg cells were also enriched directly from CD4(+) T cells cultured in the presence of rapamycin (0.1-10 nm). Mixed lymphocyte culture and polyclonal B cell stimulation with ex-vivo Treg cells were performed to assess the function of ex-vivo expanded Treg cells.
Results: The nTreg cells were expanded to more than 200-fold in 4 weeks and retained all the nTreg cell phenotypic characteristics, including high levels of FoxP3 expression. 2-fold increase in enrichment of CD4(+) CD25(+) FoxP3(+) Treg cells from CD4(+) cells was observed with rapamycin compared to cultures without rapamycin. The ex-vivo expanded Treg cells obtained from both methods were able to suppress the baboon anti-porcine xenogeneic T and B cell immune response in-vitro efficiently (more than 90% suppression at 1:1 ratio of T regulatory cells: T effector cells), and their suppression potential was retained even at 1:256 ratio. However, freshly isolated nTreg cells had only 70% suppression at 1:1 ratio, and their suppressive ability was reduced to ≤ 50% at 1:16 ratio. Furthermore, we have found that ex-vivo expanded Treg can also suppress the proliferation of B cells after polyclonal stimulation. Forty to 50 percent reduction in B cell proliferation was observed when ex-vivo expanded Treg cells were added to the culture at a 1:1 ratio. The addition of CD4(+) CD25(Neg) cells however induced vigorous proliferation.
Conclusion: Ex-vivo expanded CD4(+) CD25(+) FoxP3(+) Treg cells can be used to efficiently suppress xenogeneic immune responses by inhibiting T and B cell proliferation. These ex-vivo expanded Treg cells may also be used with other immunosuppressive agents to overcome xenograft rejection in preclinical xenotransplantation models.
© 2012 John Wiley & Sons A/S.
Similar articles
-
Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.Transplant Proc. 2009 Jan-Feb;41(1):418-21. doi: 10.1016/j.transproceed.2008.10.079. Transplant Proc. 2009. PMID: 19249569 Free PMC article.
-
Characterization and expansion of baboon CD4+CD25+ Treg cells for potential use in a non-human primate xenotransplantation model.Xenotransplantation. 2007 Jul;14(4):298-308. doi: 10.1111/j.1399-3089.2007.00416.x. Xenotransplantation. 2007. PMID: 17669171
-
Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis.Cytotherapy. 2007;9(2):144-57. doi: 10.1080/14653240601145223. Cytotherapy. 2007. PMID: 17453966
-
Potential of T-regulatory cells to protect xenografts.Curr Opin Organ Transplant. 2012 Apr;17(2):155-61. doi: 10.1097/MOT.0b013e3283508e17. Curr Opin Organ Transplant. 2012. PMID: 22273594 Review.
-
Dendritic cells as controllers of antigen-specific Foxp3+ regulatory T cells.J Dermatol Sci. 2009 May;54(2):69-75. doi: 10.1016/j.jdermsci.2009.02.001. Epub 2009 Mar 14. J Dermatol Sci. 2009. PMID: 19286352 Free PMC article. Review.
Cited by
-
Non-human Primate Regulatory T Cells and Their Assessment as Cellular Therapeutics in Preclinical Transplantation Models.Front Cell Dev Biol. 2021 Jun 15;9:666959. doi: 10.3389/fcell.2021.666959. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34211972 Free PMC article. Review.
-
ImmTAC/Anti-PD-1 antibody combination to enhance killing of cancer cells by reversing regulatory T-cell-mediated immunosuppression.Immunology. 2018 Oct;155(2):238-250. doi: 10.1111/imm.12954. Epub 2018 Jun 14. Immunology. 2018. PMID: 29791021 Free PMC article.
-
Restimulation After Cryopreservation and Thawing Preserves the Phenotype and Function of Expanded Baboon Regulatory T Cells.Transplant Direct. 2015 Feb 1;1(1):1-7. doi: 10.1097/TXD.0000000000000511. Transplant Direct. 2015. PMID: 27019869 Free PMC article.
-
Immunological challenges and therapies in xenotransplantation.Cold Spring Harb Perspect Med. 2014 Apr 1;4(4):a015578. doi: 10.1101/cshperspect.a015578. Cold Spring Harb Perspect Med. 2014. PMID: 24616201 Free PMC article. Review.
-
Xenotransplantation tolerance: applications for recent advances in modified swine.Curr Opin Organ Transplant. 2018 Dec;23(6):642-648. doi: 10.1097/MOT.0000000000000585. Curr Opin Organ Transplant. 2018. PMID: 30379724 Free PMC article. Review.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials